Inhibition of aldose reductase in human erythrocytes by vitamin C

Diabetes Research and Clinical Practice

Volumn 43, Issue 1, 1999, Pages 1-8

  Vincent, Travis E ^a   Mendiratta, Shalu ^a   May, James M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aldose reductase; Ascorbic acid; Human erythrocytes; Sorbitol

Indexed keywords

ALDEHYDE REDUCTASE; ASCORBIC ACID; SORBITOL;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; ENZYME INHIBITION; ERYTHROCYTE METABOLISM; HEMOLYSATE; HUMAN; HUMAN CELL; NORMAL HUMAN; VITAMIN METABOLISM;

ALDEHYDE REDUCTASE; ASCORBIC ACID; DEHYDROASCORBIC ACID; ENZYME INHIBITORS; ERYTHROCYTES; GLUCOSE; HEMOLYSIS; HUMANS; INTRACELLULAR MEMBRANES; NADP; SORBITOL;

EID: 0032974648     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00119-3     Document Type: Article

References (28)

1. Cogan D.G., Kinoshita J.H., Kador P.F., Robison G., Datilis M.B., Cobo L.M. et al. NIH conference. Aldose reductase and complications of diabetes. Ann. Intern. Med. 101:1984;82-91.
2. Gabbay K.H. The sorbitol pathway and the complications of diabetes. New Engl. J. Med. 288:1973;831-836.
3. Malone J.I., Leavengood H., Peterson M.J., O'Brien M.M., Page M.G., Aldinger C.E. Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects. Diabetes. 33:1984;45-49.
4. Hubinont C., Sener A., Malaisse W.J. Sorbitol content of plasma and erythrocytes during induced short-term hyperglycemia. Clin. Biochem. 14:1981;19-20.
5. Travis S.F., Morrison A.D., Clements R.S. Jr., Winegrad A.I., Oski F.A. Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway. J. Clin. Invest. 50:1971;2104-2112.
6. Hamada Y., Kitoh R., Raskin P. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes. 40:1991;1233-1240.
7. Srivastava S.K., Ansari N.H., Hair G.A., Jaspan J., Rao M.B., Das B. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties. Biochim. Biophys. Acta. 870:1986;302-311.
8. Florkowski C.M., Rowe B.R., Nightingale S., Harvey T.C., Barnett A.H. Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes. 40:1991;129-133.
9. Spielberg S.P., Shear N.H., Cannon M., Hutson N.J., Gunderson K. In-vitro assessment of a hypersensitivity syndrome associated with sorbinil. Ann. Intern. Med. 114:1991;720-724.
10. Banerjee A. Blood dehydroascorbic acid and diabetes mellitus in human beings. Ann. Clin. Biochem. 19:1982;65-70.
11. Chatterjee I.B., Banerjee A. Estimation of dehydroascorbic acid in blood of diabetic patients. Anal. Biochem. 98:1979;368-374.
12. Schorah C.J., Bishop N., Wales J.K., Hansbro P.M., Habibzadeh N. Blood vitamin C concentrations in patients with diabetes mellitus. Int. J. Vitam. Nutr. Res. 58:1988;312-318.
13. Stankova L., Riddle M., Lamed J., Burry K., Menashe D., Hart J. et al. Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism. 33:1984;347-353.
14. Levine M., Conry-Cantilena C., Wang Y.H., Welch R.W., Washko P.W., Dhariwal K.R. et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA. 93:1996;3704-3709.
15. Cunningham J.J., Mearkle P.L., Brown R.G. Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. J. Am. Coll. Nutr. 13:1994;344-350.
16. Vinson J.A., Staretz M.E., Bose P., Kassm H.M., Basalyga B.S. In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes. 38:1989;1036-1041.
17. Evans R.M., Currie L., Campbell A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. Br. J. Nutr. 47:1982;473-482.
18. Wang H., Zhang Z.B., Wen R.R., Chen J.W. Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. Diab. Res. Clin. Pract. 28:1995;1-8.
19. Iheanacho E.N., Hunt N.H., Stocker R. Vitamin C redox reactions in blood of normal and malaria-infected mice studied with isoascorbate as a non-isotopic marker. Free Radic. Biol. Med. 18:1995;543-552.
20. Pachla L.A., Kissinger P.T. Analysis of ascorbic acid by liquid chromatography with amperometric detection. Methods Enzymol. 62:1979;15-24.
21. Malone J.I., Knox G., Benford S., Tedesco T.A. Red cell sorbitol: an indicator of diabetic control. Diabetes. 29:1980;861-864.
22. Zerez C.R., Lee S.J., Tanaka K.R. Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal. Biochem. 164:1987;367-373.
23. Orringer E.P., Roer M.E. An ascorbate-mediated transmembrane-reducing system of the human erythrocyte. J. Clin. Invest. 63:1979;53-58.
24. Das B., Srivastava S.K. Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte. Arch. Biochem. Biophys. 238:1985;670-679.
25. + in human erythrocytes. J. Biol. Chem. 261:1986;4039-4045.
26. Malone J.I., Lowitt S. Measurements of tissue sorbitol in diabetes mellitus: enzyme method versus gas-liquid chromatography. Metabolism. 41:1992;224-227.
27. Nishimura C., Saito T., Ito T., Omori Y., Tanimoto T. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia. 37:1994;328-330.
28. Vinson J.A., Possanza C.J., Drack A.V. The effect of ascorbic acid on galactose-induced cataracts. Nutr. Rep. Int. 33:1986;665-668.